检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

P-052: Measurable residual disease (MRD) dynamics during maintenance with ixazomib vs placebo in 1280 newly diagnosed multiple myeloma (NDMM) patients: a pooled analysis of the TOURMALINE-MM3 and -MM4 trials

Bruno Paiva,Irene Manrique,Meletios A. Dimopoulos,Francesca Gay,Chang-Ki Min,Sonja Zweegman,Ivan Špička,Raphael Teipel,María-Victoria Mateos,Nicola Giuliani,Michele Cavo,Christine Rojas Hopkins,Weijun Fun,Kaveri Suryanarayan,Alexander Vorog,Cong Li,Bingxia Wang,Jose Estevam,Richard Labotka,Ajeeta Dash

Clinical Lymphoma Myeloma and Leukemia（2022）

引用 0|浏览4
暂无评分
关键词
multiple myeloma,ixazomib,measurable residual disease
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要